Fate Therapeutics
FATE
#9289
Rank
C$0.22 B
Marketcap
C$1.83
Share price
-4.48%
Change (1 day)
34.33%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2026 (TTM): C-$1.46

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$1.50. In 2025 the company made an earnings per share (EPS) of C-$1.64 an increase over its 2024 EPS that were of C-$2.34.

EPS history for Fate Therapeutics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.46-10.93%
2025C-$1.64-29.88%
2024C-$2.34
2022C-$4.1530.49%
2021C-$3.187.21%
2020C-$2.9745.45%
2019C-$2.0419.17%
2018C-$1.7117.65%
2017C-$1.46-3.77%
2016C-$1.51-12.4%
2015C-$1.73-3.97%
2014C-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Becton Dickinson
BDX
C$5.14-442.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C-$3.75 150.48%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C-$1.87 24.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$9.95-763.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
C-$5.97 298.10%๐Ÿ‡บ๐Ÿ‡ธ USA